These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Scotiabank lowered the firm’s price target on Geron (GERN) to $4 from $6 and keeps an Outperform rating on the shares. While the company’s Q4 ...